Efficacy of tolvaptan in a patient with right-sided heart failure and renal dysfunction refractory to diuretic therapy

The use of loop diuretics has been shown to deteriorate renal dysfunction and is associated with a poor prognosis in patients with heart failure (HF). Tolvaptan, a vasopressin V2-receptor antagonist, has been reported to be effective in treating HF due to its potent effects of water diuresis and is...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cardiol Cases
Autors principals: Joko, Yumiko, Ikemura, Nobuhiro, Miyata, Kotaro, Shiraishi, Yasuyuki, Tanaka, Hiroaki, Yoshida, Takuo, Ikegami, Yukinori, Fuse, Jun, Sakamoto, Munehisa, Momiyama, Yukihiko
Format: Artigo
Idioma:Inglês
Publicat: Japanese College of Cardiology 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6278578/
https://ncbi.nlm.nih.gov/pubmed/30534332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2014.02.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars